Philips Healthcare
Philips, one of the leading global medical companies, has made significant strides in the field of Holter Monitoring. Similar to GE, Philips entered this space through the acquisition of Zymed Holter Monitoring company. Zymed boasts an impressive track record in the industry, having been a leader in the United States for nearly 20 years. More recently, Philips expanded its presence in Holter Monitoring by acquiring BioTelemetry / CardioNet, a company that pioneered Mobile Cardiac Telemetry (MCT) monitoring.
With the addition of BioTelemetry, Philips has enhanced its Holter Monitoring capabilities beyond the established Zymed Holter technology by introducing the new ePatch. The Philips ePatch Holter Monitoring technology provides comprehensive tools for recording, analyzing, diagnosing, and transmitting ECG data in a reliable and rapid manner. One of Philips’ strengths lies in simplifying complex product technology, making it accessible to medical professionals of all skill levels. Their Holter Monitoring products exemplify this approach.
Competitive Advantage in Holter Monitoring
Philips Medical enjoys a competitive advantage in the Holter Monitoring market due to its size, success, and reputation for delivering quality products. The reliability of their Holter devices and the accuracy of their Zymed Holter Analysis software program are key selling points. Moreover, Philips offers a stable Holter Monitoring platform that seamlessly integrates with most Electronic Medical Record (EMR) systems and Hospital Information Systems (HIS). The company has traditionally been strong in serving large hospitals and clinics.
Holter Monitor Technology
In terms of Holter Monitor technology, Philips offers advanced solutions for both the devices and the analysis software. The older Digi-Trak Holter monitor has been replaced by the compact and versatile ePatch device. The Philips ePatch is available in three configurations, providing options for diverse monitoring needs. These configurations include the single-channel ePatch, the Flex single-channel with one lead, and the three-lead/two-channel version for shorter monitoring durations of 1-5 days. The Phillips Holter device has a proven track record of durability, with the latest model, the ePatch, being water-resistant.
Philips Medical’s Holter Monitoring analysis software is unique in offering the clinical advantages of the EASI Lead system. Through the use of five EASI electrodes, it captures three channels of derived 12-Lead ECG, enabling fast access to high-quality patient data.
Accreditations
When it comes to accreditations, Philips Medical ensures its Holter Monitoring devices meet the highest safety standards. These products carry the CE and FDA certifications, indicating compliance with safety regulations. Additionally, their laboratory services have been approved by the Centers for Medicare and Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF).
Legal & Safety Notice
It is worth noting that Philips Medical has not issued any public notices regarding manufacturing processes or pending litigation related to their Holter Monitoring products, underscoring their commitment to legal and safety standards.